alexa Improved Immuno-Detection of a Low-Abundance Cyclophilin Allows the Confirmation of its Expression in a Protozoan Parasite | OMICS International
ISSN: 2469-9756
Immunochemistry & Immunopathology

Like us on:

Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

Improved Immuno-Detection of a Low-Abundance Cyclophilin Allows the Confirmation of its Expression in a Protozoan Parasite

Patricia L Bustos1*, Alina E Perrone1, Natalia A Milduberger1,2 and Jacqueline Bua1,2

1Instituto Nacional de Parasitología ‘‘Dr. Mario Fatala Chabén’’- A.N.L.I.S. Malbrán, Av. Paseo Colón 568, C1063ACS, Buenos Aires, Argentina

2CAECIHS, Universidad Abierta Interamericana, Av. Montes de Oca 745, 2° piso, C1270AAH, Buenos Aires, Argentina.

*Corresponding Author:
Patricia L. Bustos
Instituto Nacional de Parasitología ‘‘Dr. Mario Fatala Chabén’’
Av. Paseo Colón 568 C1063ACS
Ciudad Autónoma de Buenos Aires, Argentina
Tel: +541143314019
E-mail: [email protected]

Received date: September 16, 2015; Accepted date: October 01, 2015; Published date: October 06, 2015

Citation: Bustos PL, Perrone AE, Milduberger NA, Bua J (2015) Improved Immuno-Detection of a Low-Abundance Cyclophilin Allows the Confirmation of its Expression in a Protozoan Parasite. Immunochem Immunopathol: Open Access 1:103. doi: 10.4172/2469-9756.1000103

Copyright: © 2015 Bustos PL, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Immunochemistry & Immunopathology

Abstract

Protein samples can be challenging to analyze due to the presence of high-abundance proteins masking lowabundance proteins of interest, such as biomarkers and novel physiological mediators. Cyclophilins are chaperones involved in the cis/trans isomerization of peptidyl-prolyl bonds in peptides or proteins and have been found in every organism sequenced to date. Although considerable progress has been made in the characterization of some cyclophilins expressed in diverse parasites invading humans, the main aspects of low-abundance members of this family remain unknown. In the present work, we present that the combined strategy of using more specific antibodies and increasing the presence of subcellular proteins in the sample, allowed us to confirm the expression of a 21.1 kDa cyclophilin for the first time in Trypanosoma cruzi.

Keywords

Low-abundance proteins; Subcellular fractionation; Anti-synthetic peptides antibodies; Cyclophilins; Trypanosoma cruzi

Introduction

Cyclophilins (CyPs) catalyse the cis/trans isomerization of peptidyl-prolyl bonds in peptides or proteins (PPIase activity) [1,2]. Genomes of some prokaryotes, reviewed by Galat [3] and all sequenced-to-date eukaryotes encode from one to several different paralogues of cyclophilins. Their nominal masses may vary from about 17 kDa (monodomain CyP) to several hundred kDa. CyPs have been localized to different cellular compartments, namely the cytoplasm [4], the membranes and mitochondria [5], the endoplasmic reticulum [6], the secretory pathway [7], the spliceosome [8], the nucleus and its membranes [9-11].

The archetypal CyP of the family is CyPA, which has been discovered as a cyclosporin A (CsA) [12] binding protein [4]. More than 20 paralogues of CyPA are expressed in the human body while expression levels and functions of numerous ORFs encoding cyclophilin-like sequences remain unknown. For example, CyPA and a 40 kDa multidomain cyclophilin (CyP-40) have been isolated in sizable quantities which indicate that some members of the cyclophilin family of proteins are abundantly expressed in different mammalian organs [4,13,14]. However, other members of the cyclophilin family may represent a challenging sample to analyze as the protein concentration range spans a few orders of magnitude and organellar proteins are generally low-abundance proteins which are extremely difficult to detect in complex samples.

Although considerable progress has been made in molecular characterization of some cyclophilins expressed in diverse parasites invading humans [15], the knowledge of functional aspects of the differentiated repertoires of the cyclophilins expressed in numerous parasites remains scarce [15,16].

Trypanosoma cruzi is the protozoan parasite that causes Chagas disease or American trypanosomiasis. This is a potentially lifethreatening illness and it is estimated that about 7 million to 8 million people are infected, mostly in Latin America, where Chagas disease is endemic, but also in other parts of the world through migration from endemic areas (WHO, 2014). The Trypanosoma cruzi cyclophilin gene family comprises 15 paralogues whose nominal masses vary from 19 to 110 kDa, but only the 4 of them with high abundance could be isolated from T. cruzi epimastigote extracts by cyclosporin A-affinity chromatography [16].

In recent years, several studies have described additional cellular functions for cyclophilins, including roles as chaperones and in cell signaling. Therefore, cyclophilins have proved to be of potential interest in elucidating physiological processes that still remain unknown.

Enrichment in low abundance proteins has become a challenge in the search of biomarkers and mediators. Efforts have been made in characterizing protein profile of biological samples such as placenta [17], urine [18] plants [19], etc. The techniques applied to this goal are diverse and include protein depletion and mass spectrometry [17,20], improved fractionation and purification methods [18], high-resolution NMR [21] among others.

Improving the detection of low-abundance proteins is also a challenge when characterizing molecules in human pathogens. The search on novel molecules to identify new drug targets and also to improve the knowledge about the biology of these microorganisms is under development, supported by improved strategies and new technologies.

In this work, we present an effective strategy for enrichment in low-abundance parasite CyPs to levels that enabled the immunological detection with more specific antibodies. This approach allowed us to identify for the first time the expression of a cyclophilin localized to the endoplasmic reticulum of the parasite.

Experimental Section

Parasites

T. cruzi CL Brener clone parasites were cultured in biphasic medium containing 1.5% nutrient agar with the addition of 0.2% rabbit defibrinated blood and Brain Heart Infusion medium (Difco Michigan, USA). Epimastigotes were collected at 5 days of culture (late log phase) at 28°C.

Antibodies anti-TcCyP21 synthetic peptide

From TcCyP21 protein sequence (GenBank Acc. Number KP792643) two specific peptides were synthesized: P1- NTKTGLNDKPKKC y P2 - VSARADPVVTD (Sigma Co., USA) and coupled to KLH carrier protein by standard procedures. Balb/c mice were immunized with five intra-peritoneal doses of KLH coupled peptide (10 mg/ml each) with Freund’s incomplete adjuvant to raise anti-mouse specific polyclonal antibodies.

Subcellular fractionation

To increase the concentration of organellar proteins in the sample, cell fractionation was performed following a described protocol [22]. Briefly, T. cruzi epimastigotes were washed three times in 15 ml MES buffer (20 mM MOPS, pH 7.0, 250 mM sucrose, 3 mM EDTA). The cell pellet was resuspended in 0.2 ml MES buffer containing 4 mg/ ml digitonin and protease inhibitors: 1 mM pepstatine A, 1 mM phenylmethylsulfonylfluoride (PMSF) and 0.1 mM Na-ptosyl-Llysine chloromethyl ketone (TLCK). The suspension was incubated at room temperature for 5 min and centrifuged at 10,000 g for 5 min. The resulting supernatant was collected as a cytosolic fraction, and the heavy membrane enriched pellet (membrane-enriched fraction) was resuspended in phosphate buffer (20 mM sodium phosphate, pH 7.0, 3 mM EDTA).

SDS-PAGE and western blot analysis

Procedures for SDS–PAGE of protein samples were carried out as described by Laemmli [23]. 107 parasites per lane were loaded for total parasite lysate. For subcellular fractionation, 108 parasites were treated with digitonin and the whole volume of the membrane-enriched fraction was loaded per lane. Polypeptides were electro-transferred from 13.5% polyacrylamide gels to nitrocellulose membranes (Whatman International Ltd., Germany), which were blocked with a 5% (W/V) non-fat milk suspension for 1 h at room temperature. After overnight incubation for 2 h with a mouse polyclonal antibody against peptide 1 (P1) or peptide 2 (P2) from TcCyP21, membranes were thoroughly washed with PBS-Tween 0.05%. A biotinylated antimouse (1:2000) was used as a secondary antibody and streptavidinhorseradish peroxidase (1:1000) was used to enhance the signal. Proteins were visualized by with an ECL Western Blotting Detection kit (GE Healthcare).

Immunofluorescence microscopy

To determine the localization and expression of TcCyP21 in T. cruzi, live epimastigotes were labelled with Mitotracker Red (Invitrogen) at 50 nM in PBS-3% glucose for 30 min at 28°C. Epimastigotes were washed in ice-cold PBS and fixed with 1% paraformaldehyde in PBS at 4°C for 1 h. The fixed parasites were washed twice with PBS, allowed to adhere to poly-L-lysine-coated coverslips and permeabilized with 0.1% TritonX-100/PBS for 5 min. After blocking with PBS containing 3% BSA for 1 h at room temperature, epimastigotes were incubated with 3% BSA/PBS with anti-P1-TcCyP21 (1:100) for 1 h. After thoroughly washing with PBS, parasites were stained with Alexa 488-conjugated goat anti-mouse antibody at 1:1,000 for 1 h. Parasites were mounted with Vectashield (Vector Labs) containing DAPI as DNA staining. Images were obtained with an Olympus DP72 camera coupled to a fluorescence microscope Olympus BX60 and analyzed with Image J software.

Results

Peptide selection for specific antibodies

In Trypanosoma cruzi genome there is a sequence for a 21.1 kDa cyclophilin (GenBank Acc. Number KP792643) named TcCyP21. This protein has a predicted signal peptide of 28 AA and it was inferred to be transcribed in different cell cyle stages: epimastigotes (AI562688, AI562266) [24] and also in trypomastigote and amastigote cDNA 132 libraries (CF889418, CB923590) [25]. However, the transcription of TcCyP21 could not be confirmed by cyclosporin A-affinity chromatography[16].

To evaluate if its expression could be detected by Western blot, antibodies against specific peptides of TcCyP21 protein were raised. To this end, we analyzed the TcCyP21 protein sequence with Bepipred- 1.0b, a free server that allows choosing the most immunogenic regions within an aminoacidic sequence [26]. Of the four peptide options that were identified by the server, two were synthesized, considering both the immunogenicity and the unconserved region of the sequence among the CyP family (Figure 1).

immunochemistry-immunopathology-Selection-immunogenic-peptides

Figure 1: Selection of immunogenic peptides from TcCyp21. The search for immunogenic sequences present in TcCyP21 was performed using the Bepipred 1.0b free server. The program suggested 4 peptides, which were classified as best epitopes (bold), very good epitopes (box) and good epitopes (underlined). Finally, the 2 peptide sequences that did not align with the conserved region were chosen for antibodies raising.

After obtaining the immune sera against each synthetic peptide, they were tested by Western blot against the recombinant protein available in our laboratory. We observed that while the antibodies against P1 were able to detect the recombinant TcCyP21, this was not the case with the anti-P2 antibodies (Figure 2).

immunochemistry-immunopathology-Anti-peptide-recombinant

Figure 2: Anti-peptide 1 could detect the recombinant TcCyP21. rTcCyP21 protein could be detected by Western blot with the specific antibodies against peptide 1 (α-P1) but not with anti-peptide 2 (α-P2) antibodies. Antibodies against the whole rTcCyP21 (α- TcCyP21) were used as positive control.

We continued our studies with the immune serum against peptide 1 from TcCyP21, identified as anti-P1.

Anti- P1 was able to detect the native TcCyP21 in a membraneenriched fraction

To evaluate if we could confirm the expression of native TcCyP21 by Western blot, we prepared two different protein samples. One of them was total parasite lysate and the other corresponded to a membraneenriched fraction (as described in the Experimental Section) to try to increase the presence of low-abundance organellar proteins. We observed that TcCyP21 could not be detected by anti-P1 in a total parasite lysate. However, when we enriched the sample in organellar membrane proteins (without most of the high-abundance cytosolic proteins), anti-P1 was able to detect a unique band of the expected size for TcCyP21 (Figure 3A).

immunochemistry-immunopathology-detect-native-membraneenriched

Figure 3: Anti -peptide 1 was able to detect native TcCyP21 in membraneenriched fractions. Anti-P1 was able to detect a unique band of the expected size for TcCyP21 in a membrane enriched fraction (F), without the highabundance cytosolic proteins. However, native TcCyP21 could not be detected by anti-P1 in a total parasite lysate (L). (B) Anti-TcCyP21 failed to detect a unique specific band of 21.1 kDa both against total parasite lysate (L) and in a membrane-enriched fraction (F). An arrow was used to indicate where the protein band corresponding to TcCyP21 was expected to be visualized.

It is important to highlight that the antibodies against the whole recombinant TcCyP21, failed to detect a unique band against these samples, probably by cross-reacting with the conserved regions of other members of the cyclophilin family (Figure 3B).

Anti- P1 reveals the native TcCyP21 subcellular localization by immunofluorescence

To confirm subcellular localization of TcCyP21, we performed immunofluorescence using the anti-P1 antibodies against the epimastigote stage of the parasite. We also used Mitotracker Deep Red as a mitochondrial marker and DAPI as nuclear staining.

We observed that TcCyP21 presented perinuclear distribution, which appears to be endoplasmic reticulum distribution and did not co-localize with the mitochondrial marker (Figure 4).

immunochemistry-immunopathology-Anti-confirm-subcellular

Figure 4: Anti -peptide 1 was able to confirm TcCyP21 perinuclear localization. Anti-P1 was used to confirm TcCyP21 subcellular localization by immunofluorescence, detected with a secondary antibody anti-mouse FITC (green). Mitotracker Deep Red was used as mitochondrial marker (red) and DAPI was used as nuclear staining (blue).

The subcellular localization of TcCyP21 was also confirmed by overexpression of TcCyp21-GFP in parasites in epimastigote stage (data not shown).

Conclusion

In the present work, we demonstrated that raising different and more specific antibodies against the TcCyP21 protein and increasing its abundance in the sample by subcellular fractionation and enrichment using digitonin, resulted in a successful strategy to confirm the expression of this low abundance cyclophilin.

This had not been possible before, especially considering that this protozoan parasite expresses two other CyPs with high abundance (TcCyP19 and TcCyP40) and conserved regions with TcCyP21. Although there was in silico evidence that this protein was expressed in the different stages of the parasite lyfe cycle, every attempt of detecting this low abundance TcCyP21 failed, when using total parasite lysate, even when the amount of cells per lane was increased 100 times. However, the TcCyP21 was successfully detected in membraneenriched fractions, confidently realted to an increased presence of this protein in the sample. Other biological samples may present similar challenges with a small number of high-abundance proteins masking the low abundance proteins of interest. Working with less complex samples obtained by any suitable enrichment protocol, such as subcellular fractionation or immunoprecipitation, may alleviate these challenges.

By using more specific antibodies against a selected peptide from TcCyP21, we were also able to avoid the cross-reactivity with the conserved regions among the protein family, which allowed us to obtain a tool for immunodetection of this protein.

The successful confirmation that this low-abundance TcCyP21 was expressed by the parasite reveals the potential of our approach for other biological samples of interest.

Acknowledgements

P.L.B. was supported by a fellowship from CONICET. We thank Dr. Alicia Graciela Fuchs and CAECIHS for supporting N.A.M. This work was financed by ANLIS Carlos G. Malbrán and Focanlis 2014, PICTO-ANLIS 00136/11 and by National Scientific and Technical Research Council (CONICET) Grant PIP 2014.

References

Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Recommended Conferences

  • International Conference on Clinical and Cellular Immunology
    August 6-7, 2018 Madrid, Spain
  • International Conference on Tumor & Cancer Immunology and Immunotherapy
    September 17-18, 2018 San Diego, USA
  • 12th International Conference on Allergy, Asthma & Clinical Immunology
    October 1-2, 2018 Moscow, Russia
  • World Congress and Expo on Immunology
    October 19-20, 2018 Baltimore, USA
  • 3rd International Conference on Autoimmunity
    November 26-27, 2018 Dublin, UK
  • 4th Antibodies, Antibiotics and Bio Therapeutics Congress
    December 05-06, 2018 Chicago, USA
  • 13th International Conference on Allergy and Clinical Immunology
    December 13-14 , 2018 Abu Dhabi, UAE

Article Usage

  • Total views: 12087
  • [From(publication date):
    October-2015 - Jun 25, 2018]
  • Breakdown by view type
  • HTML page views : 8311
  • PDF downloads : 3776

Review summary

  1. Correy
    Posted on Aug 16 2016 at 11:40 am
    This report on improve detection of low-abundance cyclophilin in a protozoan parasite. Authors have very well designed various peptides and generated specific antibodies against protein and successes to get positive results. This article talks about the recent advancements and its applications in clinical treatment.
 

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

+1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
Leave Your Message 24x7